Across TCGA pan-cancer cohorts, LINC02813 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02813 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher LINC02813 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02813 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PAAD show a favorable association.

KICH, UVM, and READ are the cancer types where LINC02813 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
UVM	DFS	Tertile	II,III,IV	0.538	0.823	.002	72	view →
READ	DFS	Tertile	All	0.320	0.627	.002	69	view →
HNSC	OS	Tertile	IV	0.288	0.565	.005	51	view →
ACC	DFS	Tertile	III,IV	0.033	0.381	<.001	45	view →
UCS	OS	Median	IV	0.240	0.616	.019	18	view →
ESCA	OS	Tertile	III,IV	0.641	0.329	.012	18	view →
COAD	OS	Tertile	All	0.796	0.882	.016	18	view →
SKCM	DFS	Quartile	IV	0.093	0.669	.008	16	view →
PAAD	DFS	Tertile	II,III,IV	0.621	0.389	.006	14	view →
BRCA	DFS	Median	III,IV	0.744	0.288	.001	12	view →
SARC	OS	Median	All	0.607	0.792	.004	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

Exploration

Same gene, other analysis: LINC02813 tumor-vs-normal RNA expression · all LINC02813 data types